Intel and Thermo Fisher Take 41% of HELO's $121 Million Buy
JPMorgan's hedged equity ETF added $28.2 million of Intel and $21.5 million of Thermo Fisher on Monday, two names that together absorbed about 41% of the fund's $121.0 million in net buying.

The JPMorgan Hedged Equity Laddered Overlay ETF (HELO) bought $28.2 million of Intel and $21.5 million of Thermo Fisher on Monday, part of $121.0 million of net buying across 18 increased positions.
JPMorgan's hedged equity ETF spent Monday putting money to work, and two of its largest cheques went to a chipmaker in the middle of a turnaround and a lab-equipment supplier that has been out of favour. The JPMorgan Hedged Equity Laddered Overlay ETF (HELO) added $28.2 million of Intel and $21.5 million of Thermo Fisher, according to trade data reported by GuruFocus. In all, the fund put through $121.0 million in net buying across 18 increased positions.
Those two trades alone account for roughly 41% of the day's net buying, an unusually concentrated pair of adds for a fund whose stated job is to own a broad slice of large-cap America with an options collar wrapped around it.
What a laddered-overlay fund is actually doing when it buys
HELO holds a portfolio of large-cap US equities and layers an options overlay on top — buying puts to cushion drawdowns and selling calls to pay for them, with the contracts staggered, or "laddered," across multiple expiry dates rather than rolled all at once. The ladder is the point: it means the fund is never fully exposed to the pricing of a single options expiry, and it means the equity sleeve underneath has to be maintained continuously rather than reset quarterly.
That has a practical consequence for how you read a day like Monday. Buying across 18 increased positions with no single name dominating the total is the signature of portfolio maintenance — rebalancing weights, deploying inflows, resetting the equity book against the hedge — rather than a discretionary bet on two companies. The related holdings disclosed alongside the trades read like a map of US mega-cap: Apple, Microsoft, Nvidia, Amazon, Alphabet and Oracle in technology; American Express, Apollo Global Management and Berkshire Hathaway's B shares in financials; Hewlett Packard Enterprise, Palo Alto Networks and CrowdStrike further down the tech stack.
Still, size carries information. A $28.2 million add to a single semiconductor name and $21.5 million to a single life-sciences name are decisions someone signed off on, and both landed in stocks that have had a conspicuous 2026.
Intel bought into a rebound, Thermo Fisher into a lull
Intel was up 2.17% at 118.44 as of 14:51 GMT on Wednesday, against a previous close of 115.93, and had traded between 116.00 and 120.41 during the session. The stock is one of the more actively debated large caps in the market: the foundry build-out, the competitive position against rival accelerator platforms, and the question of how much of the AI infrastructure spending cycle it eventually captures. Buying it in size is a view that the equity sleeve should carry semiconductor exposure beyond the obvious winners.
Thermo Fisher was quieter and slightly softer, trading at 678.71, down 0.13% from a 679.61 close, with a session range of 671.63 to 679.76. Life-sciences tools have been a laggard group relative to the index leadership: the sector's customers — pharmaceutical R&D budgets, academic labs, biotech startups — spend on equipment when funding is loose and defer when it is not. For a hedged strategy, a name like this is ballast rather than beta, and adding to it during a flat tape is consistent with maintaining diversification away from the mega-cap technology complex that dominates the rest of the holdings list.
HELO itself was up 0.45% at 69.50, with a prior close of 69.19 and a narrow 69.33 to 69.53 range. That compression is the overlay working as designed. On the same day, the S&P 500 tracker SPY rose 0.57% to $768.58 and the Nasdaq 100 tracker QQQ gained 0.76% to $743.54, while the Dow 30 tracker DIA was essentially flat at $513.04, up 0.03%.
The trade-off buyers of hedged equity accept
Wednesday's tape is a small, clean illustration of what a collar does. HELO participated in the up move but not fully: the fund's 0.45% gain trailed both broad benchmarks that rose. Selling calls to fund downside protection caps the upside, and on green days that cap is visible. On red days the puts are what investors are paying for.
Selling calls to fund downside protection caps the upside, and on green days that cap is visible.
Investors weighing this structure should be clear about the bargain:
- You give up the tail of the rally. In strong months, a collared portfolio will lag an unhedged index fund, and the gap compounds over long bull runs.
- You buy a narrower distribution of outcomes. The point is a smoother path, not a higher terminal number.
- The cost is embedded, not billed. Hedging expense shows up in foregone upside rather than as a line item, which makes it easy to underestimate.
- The equity sleeve still matters. An overlay does not rescue poor stock selection — it compresses the range around whatever the underlying book delivers.
What the trade tells you and what it does not
One day of buying does not establish a thesis. Net buying across 18 positions means the fund was a buyer on balance, but the disclosure as reported does not break out what was trimmed or how the new dollars change each holding's weight. A $28.2 million purchase is meaningful in absolute terms and may be immaterial as a percentage of the position depending on how large that position already was.
What is worth tracking is whether the pattern repeats. If Intel and Thermo Fisher keep appearing at the top of HELO's buy tickets over successive sessions, that is a deliberate tilt — toward a semiconductor turnaround story and toward a defensive healthcare-adjacent industrial. If they do not, Monday was housekeeping, and the interesting number is the $121.0 million total rather than the two names inside it.
The broader signal for anyone watching institutional flow is simply that hedged strategies were net buyers into a market sitting near the top of its recent range. Funds that own protection have a structural reason to stay invested when unhedged managers might be reducing exposure — which is, in the end, the whole argument for owning the hedge in the first place.
Key facts
- HELO price: 69.50, +0.45% as of 14:51 GMT, 30 Sep 2026
- Intel (INTC): 118.44, +2.17%; day range 116.00–120.41
- Thermo Fisher (TMO): 678.71, -0.13%; day range 671.63–679.76
- Monday's net buying: $121.0 million across 18 increased positions
Frequently asked questions
How much did HELO buy of Intel and Thermo Fisher?
The JPMorgan Hedged Equity Laddered Overlay ETF purchased $28.2 million of Intel and $21.5 million of Thermo Fisher in Monday's session. Those two trades were part of a broader $121.0 million of net buying spread across 18 positions the fund increased that day, making them the two largest single-name additions disclosed.
What does a laddered overlay ETF actually do?
It holds a portfolio of large-cap stocks and adds an options collar: buying put options to limit downside and selling call options to help pay for them. The contracts are staggered across several expiry dates rather than rolled all at once, so the fund is not dependent on the option pricing available on any single day.
Why did HELO gain less than the S&P 500 on Wednesday?
HELO rose 0.45% while the S&P 500 tracker SPY gained 0.57% and the Nasdaq 100 tracker QQQ rose 0.76%, as of 14:51 GMT on 30 September 2026. Selling call options to fund downside protection caps upside participation, so a collared fund typically trails a rising index. The trade-off is cushioning when markets fall.
What other stocks are associated with HELO's holdings?
The related holdings disclosed alongside Monday's trades include Apple, Microsoft, Nvidia, Amazon, Alphabet and Oracle, plus Hewlett Packard Enterprise, Palo Alto Networks and CrowdStrike in technology, and American Express, Apollo Global Management and Berkshire Hathaway's Class B shares in financials. It is a broadly mega-cap US equity book.
How did Intel stock trade on the day of the report?
Intel was quoted at 118.44 as of 14:51 GMT on 30 September 2026, up 2.17% from a previous close of 115.93. The stock traded between 116.00 and 120.41 during the session, making it one of the stronger large-cap movers on a day when the broad market indices posted modest gains.
Does one day of fund buying signal a long-term view?
Not on its own. Net buying across 18 positions is consistent with routine portfolio maintenance — deploying inflows or rebalancing the equity sleeve against the options hedge. The disclosure does not show what was trimmed or how the purchases changed each position's weight. Repeated appearances at the top of the buy list over several sessions would carry more signal.
Sources
Photo: 3844328 · Pixabay Content License — source


